 Connection
John Carroll to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications John Carroll has written about Randomized Controlled Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.741 |
|
|
|
-
Carroll JD. Migraine Intervention With STARFlex Technology trial: a controversial trial of migraine and patent foramen ovale closure. Circulation. 2008 Mar 18; 117(11):1358-60.
Score: 0.209
-
Carroll AM, Carroll JD. Device Closure of Patent Foramen Ovale for Cryptogenic Stroke: Patient Selection and Outcomes According to New Randomized Trials. Curr Cardiol Rep. 2019 04 22; 21(6):48.
Score: 0.113
-
Wiktor DM, Carroll JD. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke. Circ Cardiovasc Interv. 2018 03; 11(3):e004152.
Score: 0.105
-
Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, J?ni P, Mattle HP, Meier B, Thaler DE. Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials. J Am Coll Cardiol. 2016 Mar 01; 67(8):907-917.
Score: 0.091
-
Dattilo PB, Kim MS, Carroll JD. Patent foramen ovale. Cardiol Clin. 2013 Aug; 31(3):401-15.
Score: 0.076
-
Kim MS, Klein AJ, Carroll JD. Transcatheter closure of intracardiac defects in adults. J Interv Cardiol. 2007 Dec; 20(6):524-45.
Score: 0.051
-
Kent DM, Saver JL, Kasner SE, Nelson J, Carroll JD, Chatellier G, Derumeaux G, Furlan AJ, Herrmann HC, J?ni P, Kim JS, Koethe B, Lee PH, Lefebvre B, Mattle HP, Meier B, Reisman M, Smalling RW, Soendergaard L, Song JK, Mas JL, Thaler DE. Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke. JAMA. 2021 12 14; 326(22):2277-2286.
Score: 0.034
-
Lakkireddy D, Windecker S, Thaler D, S?ndergaard L, Carroll J, Gold MR, Guo H, Brunner KJ, Hermiller JB, Diener HC, Schmidt B, MacDonald L, Mansour M, Maini B, Levine J. Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial). Am Heart J. 2019 05; 211:45-53.
Score: 0.028
-
Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, Trelle S, Windecker S, Meier B, J?ni P. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J. 2015 Jan 07; 36(2):120-8.
Score: 0.020
-
Lansky AJ, Tsuchiya Y, Brener M, Mehran R, Cristea E, Pietras C, Grines CL, Cox DA, Garcia E, Tcheng JE, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Leon MB, Moses J, Stone GW. Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial. Catheter Cardiovasc Interv. 2008 Dec 01; 72(7):917-24.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|